Uses artificial intelligence and neural nets for drug discovery.
Develop algorithms and interpretation software for radiologists.
Analytics 4 Life is applying artificial intelligence to produce novel diagnostic images, transforming medicine through digital health technology.
Atomwise is the creator of AtomNet, the first Deep Learning technology for novel small molecule discovery.
BioXcel is a biopharmaceutical company that uses artificial intelligence and big data analytics to develop medicines in immuno-oncology, neuroscience, and rare diseases with high unmet need
CAMP4 has built a proprietary 4-D Gene Circuity Platform to codify the discrete set of combinatorial rules used by any human cell type central to disease pathology.
Cellari provides software for bioimage segmentation, workflows, and statistical analyses.
CuraCloud™ uses artificial intelligence (AI) algorithms for medical image analysis, clinical results mining, molecular oncology and other areas of medicine and research.
CytoReason has developed the first machine learning model of the immune system
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Their proprietary and patented technologies oriented around deciphering the ...
For more than 15 years, Enthought has built AI solutions with science and engineering at the core.
An innovation foundry.
Freenome is using advanced computer learning to enable earlier, more effective treatment for millions of patients. The company is developing computational methods to create effective tools for ...
InterVenn is combining mass spectrometry and artificial intelligence to identify glycoproteins for biomarker and target discovery.
Juvenescence AI Limited is a drug development and artificial intelligence company focussed on ageing and age-related diseases.
Founded in 2001, Linguamatics uses natural language processing (NLP)-based text mining for high-value knowledge discovery and decision support.
Livongo evaluates real-time data and patterns to personalize member experiences to drive behavior change, redesigning chronic condition management, starting with diabetes.
Using video capture and analysis to detect movement disorder diseases like Parkinson's.
MedyMatch is creating a new category of AI-driven diagnostic tools. Leveraging the richness of 3D imaging, the breadth of patient-specific data, and other relevant data, concurrently, the company ...
Optalysys was formed to solve some of the fundamental limitations of conventional computing. The company's optical co-processors use low power laser light to perform processor intensive ...
Paige.AI is using artificial intelligence to diagnose and treat of cancer with the goals of rapid stratification to tumor detection, segmentation, and prediction of treatment response and survival ...
PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses.
Phenomix has created a new test using a Phenotype-driven multi-omics application to predict responses to current FDA approved obesity interventions.
Prognos’ AI platform enables early prediction of disease onset, therapy need, clinical trial opportunity, care gaps, and risk, using clinical algorithms across 30+ conditions.
Recursion uses automated laboratory processes and analytics based on an artificial intelligence platform that allows it to conduct some 100,000 cellular experiments a week. The company uses this ...
RenalytixAI is a developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally.
RowAnalytics is a precision medicine company with patented A.I. deep semantic technology for search, discovery and decision support. Our novel high-dimensional analytics find patterns of features ...
Singlera Genomics is committed to the application of next generation sequencing to diagnose genetic diseases and disorders. Singlera Genomics develops non-invasive genetic tests using proprietary ...
Clinical Next Gen Sequencing Dry Lab Service
SpIntellx is a computational pathology company developing novel AI tools based on spatial analytics.
twoXAR is an artificial intelligence-driven drug discovery company.